Active Ingredient: NAPROXEN
Proprietary Name: NAPROXEN
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 25MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A212705
Product Number: 001
Approval Date: Jul 31, 2020
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information